Commercial Real Estate Deal Growth Stalls: What Slowing Momentum Means for 2026

Commercial real estate cityscape

Commercial real estate investors hit the brakes this October, marking the first year‑over‑year decline in deal volume since early 2024. After nearly two years of strong momentum, the market’s sudden hesitation has thrown a spotlight on widening pricing gaps, elevated financing costs, and the ongoing standoff between CRE buyers and sellers.

According to Mortgage Professional America, the slowdown doesn’t signal a collapse—rather, it underscores how far pricing expectations have drifted apart in today’s high‑rate environment. Kevin Fagan, head of CRE capital market research at Moody’s, described October’s numbers as a sign of an extended stalemate rather than an impending downturn.

Deal Volume Still Active, but Momentum Slows

Despite the cooling pace, October still delivered $24.4 billion in U.S. CRE sales—roughly 70% of the volume seen in October 2019. Total 2025 deal activity remains above 2024 levels. But as Moody’s data shared with CNBC reveals, the rapid growth seen in late 2024 and early 2025 has lost steam.

Multifamily took the sharpest hit, with a steep 27% drop in October deal volume. Yet, many multifamily assets still trade at premiums—showing that while demand is strong, pricing has become more tangled and competitive.

Hospitality Surges as Conversions Reshape the Market

The hospitality sector emerged as the only segment with a year‑over‑year increase, rising approximately 6%. A standout transaction was the sale of the New York Edition hotel from Abu Dhabi Investment Authority to Kam Sang Company for $231.2 million.

Kevin Fagan highlights a broader trend: struggling office buildings transforming into valuable hotel or residential conversions. Iconic projects such as the Woolworth Building illustrate how adaptive reuse continues to redefine the CRE landscape.

Meanwhile, value‑seeking buyers made headlines when New York Life acquired a Manhattan office tower for nearly half its 2015 valuation. Institutional investors are circling distressed but well‑located assets—hinting that prime office space still offers long‑term promise.

Commercial Mortgages: A Volatile but Active Landscape

The third quarter of 2025 brought a powerful resurgence in mortgage originations. According to the Mortgage Bankers Association, commercial and multifamily lending jumped 36% year‑over‑year.

Even more surprising: office lending surged 181%. Despite the sector’s challenges, lenders are selectively backing properties with conversion potential or those supported by medical and life‑science tenants—two fields rapidly absorbing obsolete office inventory.

What This Means for 2026

This slowdown suggests 2026 will be shaped not only by fundamentals like rent growth and occupancy, but by how quickly market participants recalibrate expectations in a higher‑cost environment.

For commercial originators, investors, brokers, and analysts, this means strengthening market literacy—particularly around evolving debt markets, valuation resets, and underwriting shifts. And professionals entering or upskilling in real estate, mortgage, or finance will need sharper insights and stronger training than ever.

This is where institutions like Cameron Academy play a crucial role. With licensing education, continuing education, and professional development across real estate, mortgage, insurance, and financial services, Cameron Academy helps future‑focused professionals stay competitive, confident, and opportunity‑ready.

As the market transitions into its next cycle, knowledge isn’t just power—it’s deal flow, resilience, and long‑term career growth.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Boom in Cancer: Game-Changer or Just Hype?

The promise of artificial intelligence (AI) in the field of oncology is nothing short of revolutionary. As the world grapples with the complexities of cancer, AI is emerging as a potential game-changer in diagnostics, treatment personalization, and drug discovery.

By |January 15, 2025|Categories: Article, Healthcare, Technology|Tags: |0 Comments

HHS Unveils AI Strategic Plan to Revolutionize Healthcare

The U.S. Department of Health and Human Services (HHS) has unveiled its ambitious AI Strategic Plan, a comprehensive blueprint aimed at revolutionizing healthcare, human services, and public health through the transformative power of artificial intelligence.

By |January 15, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

United States Naval Academy Class of 2024 Graduation

The ceremony was graced by the presence of three distinguished speakers, whose words of wisdom and encouragement left a lasting impression on the attendees.

By |January 14, 2025|Categories: Article, Education, Military|Tags: , |0 Comments

AI Certifications: The Key to Future-Proofing Your Career

In the fast-paced world of artificial intelligence (AI), staying current with the latest technological advancements is crucial for professionals aiming to excel in their careers. As businesses increasingly integrate AI into their operations, the demand for skilled AI experts is surging.

By |January 14, 2025|Categories: Article, Education, Technology|Tags: , |0 Comments

Telemedicine: A Digital Revolution in Healthcare Amid COVID-19

The year 2020 marked a significant turning point in the global healthcare landscape, as the COVID-19 pandemic accelerated the adoption of digital technologies such as telemedicine.

By |January 14, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Genomic Biomarkers Market Thrives with Personalized Medicine Boom

The genomic biomarkers market is witnessing a significant surge, driven by the burgeoning demand for personalized medicine. According to the latest report, the market is projected to grow to $14.09 billion by 2028, marking a compound annual growth rate (CAGR) of 17.4%. This approach not only optimizes treatment effectiveness but also minimizes side effects, making it a cornerstone of modern healthcare.